Stock A048530 INTRON BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company iNtRON Biotechnology, Inc.

Equities

A048530

KR7048530000

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
6,390 KRW -0.31% Intraday chart for iNtRON Biotechnology, Inc. -1.99% -27.22%
03-13 INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-15 Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer CI

Business Summary

iNtRON Biotechnology, Inc. is a Korea-based company principally engaged in the biotechnology industry. The Company operates its business through two main divisions: genetic reagent division and molecular diagnostics division. Its genetic reagent division is involved in the research and development of reagents, which are under the brand names of Maxime and pLUG for life science research. Its molecular diagnostics division is engaged in the development and production of nucleic acid tester for infectious diseases. It also engages in the operation of veterinary antibiotic alternative business and new biopharmaceuticals development business. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 81

Sales per Business

KRW in Million2022Weight2023Weight Delta
Immuno-oncology Drugs - Product
83.2 %
12,657 90.4 % 7,976 83.2 % -36.98%
Transfer of Technology
13.6 %
1,066 7.6 % 1,307 13.6 % +22.61%
Service
2.3 %
185 1.3 % 218 2.3 % +17.86%
Immuno-oncology Drugs - Merchandise
0.9 %
98 0.7 % 83 0.9 % -14.83%
Other
0.0 %
1 0.0 % 1 0.0 % -35.91%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea and United States
100.0 %
14,007 100.0 % 9,585 100.0 % -31.57%

Managers

Managers TitleAgeSince
Gyeong-Won Yoon CEO
 Chief Executive Officer 52 02/12/01
Seong-Joon Yoon CEO
 Chief Executive Officer 55 11/05/00
Jae-Goo Seol BRD
 Director/Board Member 55 -
Sang-Hyeon Gang BRD
 Director/Board Member 56 -
Jong-Seong Yoon AUD
 Comptroller/Controller/Auditor 52 -
Man-Soon Park PRN
 Corporate Officer/Principal 51 -
Ji-Seong Park PRN
 Corporate Officer/Principal 52 -

Members of the board

Members of the board TitleAgeSince
Yoon-Sun Yang BRD
 Director/Board Member 59 -
Seong-Joon Yoon CEO
 Chief Executive Officer 55 11/05/00
Gyeong-Won Yoon CEO
 Chief Executive Officer 52 02/12/01
Sang-Hyeon Gang BRD
 Director/Board Member 56 -
Man-Soon Park PRN
 Corporate Officer/Principal 51 -
Jae-Goo Seol BRD
 Director/Board Member 55 -
Myeong-Hoon Seong BRD
 Director/Board Member 67 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 34,150,762 27,756,342 ( 81.28 %) 959,215 ( 2.809 %) 81.28 %

Shareholders

NameEquities%Valuation
Seong-Joon Yoon
14.35 %
4,900,000 14.35 % 25 M ₩
INTRON BIOTECHNOLOGY, INC.
2.809 %
959,215 2.809 % 5 M ₩
NORD MASON CO., LTD.
1.946 %
664,457 1.946 % 3 M ₩
Gyeong-Won Yoon
1.230 %
420,184 1.230 % 2 M ₩
Sang-Hyeon Gang
0.2459 %
83,968 0.2459 % 423 455 ₩
MEDIPOST CO., LTD.
0.1661 %
56,710 0.1661 % 285 991 ₩
Ji-Seong Park
0.1606 %
54,848 0.1606 % 276 601 ₩
REYON PHARMACEUTICAL CO., LTD.
0.1376 %
47,000 0.1376 % 237 023 ₩
Man-Soon Park
0.1089 %
37,186 0.1089 % 187 531 ₩
Pension Reserves Investment Management Board
0.0333 %
11,380 0.0333 % 57 390 ₩

Holdings

NameEquities%Valuation
INTRON BIOTECHNOLOGY, INC.
2.81%
 959,215 2.81% 4,837,369 $
REYON PHARMACEUTICAL CO., LTD.
1.54%
 287,000 1.54% 2,861,485 $
MEDIPOST CO., LTD.
0.19%
 64,512 0.19% 330,938 $

Company contact information

iNtRON Biotechnology, Inc.

Unit 701-704, Joong-Ang Induspia 137 Sagimakgol-ro

13202, Seongnam-si

+

http://www.intron.co.kr
address iNtRON Biotechnology, Inc.(A048530)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per Business

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
INTRON BIOTECHNOLOGY, INC. Stock iNtRON Biotechnology, Inc.
-27.22% 156M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+8.63% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+13.17% 107B
BIONTECH SE Stock BioNTech SE
-12.76% 22.22B
ARGENX SE Stock argenx SE
-2.74% 21.28B
BEIGENE, LTD. Stock BeiGene, Ltd.
-7.19% 17.51B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.93% 17.17B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.67% 14.14B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.90% 12.2B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-28.60% 7.83B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A048530 Stock
  4. Company iNtRON Biotechnology, Inc.